Total Payments
$85,855
2024 Payments
$39.99
Companies
6
Transactions
108
Payment Breakdown by Category
Other$58,850 (68.5%)
Travel$18,934 (22.1%)
Education$3,460 (4.0%)
Research$2,464 (2.9%)
Food & Beverage$2,147 (2.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $58,850 | 19 | 68.5% |
| Travel and Lodging | $18,934 | 35 | 22.1% |
| Education | $3,460 | 3 | 4.0% |
| Unspecified | $2,464 | 18 | 2.9% |
| Food and Beverage | $2,147 | 33 | 2.5% |
Payments by Type
General
$83,391
90 transactions
Research
$2,464
18 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TESARO, Inc. | $85,581 | 103 | $0 (2019) |
| Neomend, Inc. | $77.87 | 1 | $0 (2017) |
| Surgical Theater LLC | $58.41 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $57.72 | 1 | $0 (2017) |
| Moderna TX, Inc. | $40.00 | 1 | $0 (2021) |
| GlaxoSmithKline, LLC. | $39.99 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39.99 | 1 | GlaxoSmithKline, LLC. ($39.99) |
| 2021 | $40.00 | 1 | Moderna TX, Inc. ($40.00) |
| 2019 | $150.00 | 1 | TESARO, Inc. ($150.00) |
| 2018 | $450.00 | 3 | TESARO, Inc. ($450.00) |
| 2017 | $85,175 | 102 | TESARO, Inc. ($84,981) |
All Payment Transactions
108 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/16/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $39.99 | General |
| 11/17/2021 | Moderna TX, Inc. | — | Travel and Lodging | In-kind items and services | $40.00 | General |
| 01/01/2019 | TESARO, Inc. | ZEJULA (Drug) | — | Cash or cash equivalent | $150.00 | Research |
| Study: A STUDY OF NIRAPARIB IN PATIENTS WITH OVARIAN CANCER WHO HAVE RECEIVED AT LEAST THREE PREVIOUS CHEMOTHERAPY REGIMENS • Category: ONCOLOGY | ||||||
| 03/01/2018 | TESARO, Inc. | ZEJULA (Drug) | — | Cash or cash equivalent | $150.00 | Research |
| Study: A STUDY OF NIRAPARIB IN PATIENTS WITH OVARIAN CANCER WHO HAVE RECEIVED AT LEAST THREE PREVIOUS CHEMOTHERAPY REGIMENS • Category: ONCOLOGY | ||||||
| 02/01/2018 | TESARO, Inc. | ZEJULA (Drug) | — | Cash or cash equivalent | $150.00 | Research |
| Study: A STUDY OF NIRAPARIB IN PATIENTS WITH OVARIAN CANCER WHO HAVE RECEIVED AT LEAST THREE PREVIOUS CHEMOTHERAPY REGIMENS • Category: ONCOLOGY | ||||||
| 01/01/2018 | TESARO, Inc. | ZEJULA (Drug) | — | Cash or cash equivalent | $150.00 | Research |
| Study: A STUDY OF NIRAPARIB IN PATIENTS WITH OVARIAN CANCER WHO HAVE RECEIVED AT LEAST THREE PREVIOUS CHEMOTHERAPY REGIMENS • Category: ONCOLOGY | ||||||
| 12/01/2017 | TESARO, Inc. | ZEJULA (Drug) | — | Cash or cash equivalent | $150.00 | Research |
| Study: A STUDY OF NIRAPARIB IN PATIENTS WITH OVARIAN CANCER WHO HAVE RECEIVED AT LEAST THREE PREVIOUS CHEMOTHERAPY REGIMENS • Category: ONCOLOGY | ||||||
| 11/01/2017 | TESARO, Inc. | ZEJULA (Drug) | — | Cash or cash equivalent | $150.00 | Research |
| Study: A STUDY OF NIRAPARIB IN PATIENTS WITH OVARIAN CANCER WHO HAVE RECEIVED AT LEAST THREE PREVIOUS CHEMOTHERAPY REGIMENS • Category: ONCOLOGY | ||||||
| 10/30/2017 | TESARO, Inc. | ZEJULA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| Category: ONCOLOGY | ||||||
| 10/27/2017 | TESARO, Inc. | ZEJULA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,400.00 | General |
| Category: ONCOLOGY | ||||||
| 10/27/2017 | TESARO, Inc. | ZEJULA (Drug) | Travel and Lodging | In-kind items and services | $439.50 | General |
| Category: ONCOLOGY | ||||||
| 10/27/2017 | TESARO, Inc. | ZEJULA (Drug) | Travel and Lodging | In-kind items and services | $403.80 | General |
| Category: ONCOLOGY | ||||||
| 10/27/2017 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $98.58 | General |
| Category: ONCOLOGY | ||||||
| 10/27/2017 | TESARO, Inc. | ZEJULA (Drug) | Travel and Lodging | In-kind items and services | $74.56 | General |
| Category: ONCOLOGY | ||||||
| 10/27/2017 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $34.93 | General |
| Category: ONCOLOGY | ||||||
| 10/20/2017 | Surgical Theater LLC | Surgical Navigation Advanced Platform (SNAP) (Device) | Food and Beverage | Cash or cash equivalent | $58.41 | General |
| Category: Surgical Planning/Navigation-Enhancement System | ||||||
| 10/16/2017 | TESARO, Inc. | ZEJULA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,400.00 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2017 | TESARO, Inc. | ZEJULA (Drug) | Travel and Lodging | In-kind items and services | $678.25 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2017 | TESARO, Inc. | ZEJULA (Drug) | Travel and Lodging | In-kind items and services | $670.96 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2017 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $59.43 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2017 | TESARO, Inc. | ZEJULA (Drug) | Travel and Lodging | In-kind items and services | $46.51 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2017 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: ONCOLOGY | ||||||
| 10/12/2017 | TESARO, Inc. | ZEJULA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: ONCOLOGY | ||||||
| 10/12/2017 | TESARO, Inc. | ZEJULA (Drug) | Travel and Lodging | In-kind items and services | $976.60 | General |
| Category: ONCOLOGY | ||||||
| 10/12/2017 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A STUDY OF NIRAPARIB IN PATIENTS WITH OVARIAN CANCER WHO HAVE RECEIVED AT LEAST THREE PREVIOUS CHEMOTHERAPY REGIMENS | TESARO, Inc. | $2,464 | 18 |
About Dr. Divya Gupta, MD
Dr. Divya Gupta, MD is a Obstetrics & Gynecology healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134209695.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Divya Gupta, MD has received a total of $85,855 in payments from pharmaceutical and medical device companies, with $39.99 received in 2024. These payments were reported across 108 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($58,850).
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Gynecologic Oncology
- Location Hartford, CT
- Active Since 10/17/2006
- Last Updated 04/04/2016
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1134209695
Products in Payments
- ZEJULA (Drug) $85,581
- DAV-Arista AH (Device) $77.87
- Surgical Navigation Advanced Platform (SNAP) (Device) $58.41
- LYNPARZA (Drug) $57.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Hartford
Dr. Alan Fine, Md, MD
Obstetrics & Gynecology — Payments: $194,586
Obstetrics & Gynecology $194,586
Dr. Adam Steinberg, Do, DO
Obstetrics & Gynecology — Payments: $138,680
Obstetrics & Gynecology $138,680
Frederick Rau, Md, MD
Obstetrics & Gynecology — Payments: $137,252
Obstetrics & Gynecology $137,252
Theodoros Kapetanakis, M.d, M.D
Obstetrics & Gynecology — Payments: $7,134
Obstetrics & Gynecology $7,134
Elizabeth Deckers, M.d, M.D
Obstetrics & Gynecology — Payments: $5,037
Obstetrics & Gynecology $5,037
Michael Bourque, Md, MD
Obstetrics & Gynecology — Payments: $4,290
Obstetrics & Gynecology $4,290